Kanye West denies all Lloyd’s counterclaims in $10m lawsuit

Singer Kanye West, through attorneys of his touring company Very Good Touring denied “each and every allegation and mischaracterization in the counterclaim” made by Lloyd’s syndicates with respect to a cancelled tour.

At the beginning of August, West filed a $10 million lawsuit against a group of Lloyd’s syndicates including Cathedral, Liberty, XL Catlin, Markel and Allianz.

West claims that the syndicates are stalling on paying out claims emanating from the “cancellation, abandonment and non-appearance” for his 2016 Saint Pablo Tour.

Following Kanye West’s reported illness and admission to UCLA Medical Center, West’s touring company Very Good Touring made a claim for benefits under the policies. West was hospitalized at UCLA for approximately a week after his admission.

Underwriters thereafter engaged in a series of communications with the insured’s representatives and obtained documentation and other information with respect to the claim. Based upon the results of that investigation to date, underwriters are informed and believe that coverage is likely precluded under the policies.

Underwriters’ investigation indicates substantial irregularities in Mr. West’s medical history, according to a court filing.

In a response to the counterclaim, West’s attorneys said that “most of the requests for information and documents were patently an effort to stall payment on the claim, in the still continuing effort by defendants to avoid parting with their funds.”

Very Good denies that there are substantial irregularities in West’s medical records. The company also denies the allegations that Very Good “failed to cooperate in the investigation” and that it “hindered, stalled, refused to provide relevant and necessary information” throughout the investigation.

Get the latest re/insurance news sent to your inbox every day -  Sign up to our free email newsletters

Allstate estimates August cat losses at $593m

Towergate’s new holding Ardonagh sees profitability rise in H1

New technology can help insurers verify photographic evidence

Markel expands equine team with MS Amlin hire

Don't miss our insurtech email newsletter - sign up today